DNA-RNA synthesis inhibitor, CX-5461, Purity ≥98%

Cat. No.: X24-08-YM090

DNA-RNA synthesis inhibitor, CX-5461, Purity ≥98%

Synonym: 1138549-36-6; CX5461; 2-(4-Methyl-1,4-diazepan-1-yl)-N-[(5-methylpyrazin-2-yl)methyl]-5-oxo-[1,3]benzothiazolo[3,2-a][1,8]naphthyridine-6-carboxamide

  • CAS Number: 1138549-36-6
  • Compound CID: 25257557
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
CX-5461, soluble in DMSO and warmed ethanol and insoluble in water, is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting DNA-RNA synthesis. It targets the A375, HCT-116, MIA PaCa-2, and Pol I-driven transcription of rRNA (HCT-116, A375, MIA PaCa-2 cells).
Molecular Weight
513.6
Molecular Formula
C27H27N7O2S
Targets
A375: 58 nM (ED50); HCT-116: 167 nM (ED50); MIA PaCa-2: 74 nM (ED50); Pol I-driven transcription of rRNA (HCT-116, A375, MIA PaCa-2 cells): 142 nM
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: <1 mg/mL; Water: insoluble; DMF (warmed): 3 mg/mL (5.84 mM)
Applications
CX-5461 is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of cancer, especially after cancer stem cells have been sensitized to chemotherapy.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0